Potent Antiviral Activity in Completed Study in Hepatitis C Patients

[joreth]

http://www.breitbart.com/article.php?id=prnw.20090423.LA04017&show_article=1

Anadys Pharmaceuticals, Inc. announced that ANA598, the Company's investigational non-nucleoside polymerase inhibitor, demonstrated potent antiviral activity at all dose levels and was well tolerated in a Phase Ib study in which patients chronically infected with the Hepatitis C virus (HCV) were treated for three days.

This is a rather dry and technical article all about a new drug that appears very promising, with few side effects, in treating Hepatitus C.  It will be a while before it's on the market, since these things take many years in the testing process to pass through FDA regulations.  But the drug makers are hopeful.

Down at the end, there's also a bit about what Hep C is.  It's a pretty serious virus, but passed through fluid transmission, so ... wear a condom and get tested regularly!  Plus, get the Hep vaccine!

Comments

[dancergeek.livejournal.com]

There is a HepC vaccine?

[joreth]

My mistake. There's a vaccine for HepA and HepB (I don't keep up with hepititis nearly as well as HPV). Here's a short breakdown of the types of Hepititis, what they do, and treatment: http://www.cdc.gov/hepatitis/

The HepC vaccine is on its way though:
http://www.hepatitis-central.com/mt/archives/2009/02/hepatitis_c_vac.html
http://www.sciencedaily.com/releases/2009/04/090423082642.htm